Obesity trials in Netherlands

In Netherlands 47 Also abroad 2008

37 of 47 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity (MARITIME-HF)
Where
Amsterdam, Arnhem, Breda, Delft, Deventer, Dordrecht, Eindhoven, Emmen, Enschede, Groningen, Heerlen, Leeuwarden, Rotterdam, 's-Gravenhage, Sneek, Venlo, Zaandam
Age
18 years and over
People
2,787 worldwide
Run by
Amgen Inc.
See details and how to join2024-516654-22-00
No phaseTaking people
How the Body Processes Sugar After Eating, in People With Different Body Weights
Where
Wageningen
Age
18 years to 65 years
People
24
Run by
Wageningen University
See details and how to joinNCT07690176
Phase 3Active, not recruiting
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Where
Amsterdam, Nijmegen, Rotterdam, Utrecht, Zwolle
Age
18 years and over
People
2,000 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00
Phase 3Not yet taking people in Netherlands
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Where
Deventer, Dordrecht, Eindhoven, Haarlem, Heerlen, Hoogeveen, Nijmegen, Utrecht
Age
18 years and over
People
1,408 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07919405
Phase 3Taking people
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Where
Amsterdam, Nijmegen, Rotterdam, Utrecht
Age
18 years to 70 years
People
350 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937086 · EU 2024-520209-38-00
Phase 3Taking people
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Where
Amsterdam, Nijmegen, Rotterdam, Utrecht
Age
18 years to 70 years
People
290 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT06937099 · EU 2024-520210-21-00
Phase 3Taking people
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Where
Amsterdam, Arnhem, Breda, Delft, Deventer, Dordrecht, Eindhoven, Emmen, Enschede, Groningen, Heerlen, Leeuwarden, Rotterdam, Sneek, The Hague, Venlo, Zaandam
Age
18 years to 99 years
People
5,056 worldwide
Run by
Amgen
See details and how to joinNCT07037459
Phase 3Taking people
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Where
Alkmaar, Almelo, Amsterdam, Beverwijk, Deventer, Eindhoven, Enschede, Hardenberg, Heerlen, Helmond, Leiderdorp, Rotterdam, 'S-Hertogenbosch, Tiel, Utrecht
Age
45 years to 64 years
People
8,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00
Phase 1Taking people
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Overweight or Obesity, Compared to a Low-calorie Diet or Placebo
Where
Maastricht
Age
18 years and over
People
120 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07757087 · EU 2025-522744-40-00
Phase 3Taking people
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Where
'S-Hertogenbosch
Age
8 years to 18 years
People
460 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00
Phase 3Active, not recruiting
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Arnhem, Born, Hoofddorp, Hoogeveen, Rotterdam, 's-Gravenhage, 's-Hertogenbosch
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
No phaseNot yet taking people in Netherlands
NutrImmune: Precision Nutrition to Improve Immunity in Individuals With Obesity
Where
Amsterdam
Age
40 years to 70 years
People
168 worldwide
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT07850206
Phase 3Active, not recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Where
Amsterdam, Zwijndrecht, Zwolle
Age
18 years and over
People
450 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07770841 · EU 2025-524626-18-00
Phase 1Taking people
A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors
Where
Groningen
Age
18 years to 75 years
People
114
Run by
AC Immune SA
See details and how to joinNCT07463196 · EU 2025-523885-25-00
Phase 1Taking people
A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity
Where
Groningen
Age
18 years to 65 years
People
128
Run by
Novo Nordisk A/S
See details and how to joinNCT07693868
No phaseNot yet taking people in Netherlands
Long-term Effects of Avocado Consumption on Health in Pre-diabetic Individuals
Where
Maastricht
Age
40 years to 75 years
People
34
Run by
Maastricht University Medical Center
See details and how to joinNCT07752225
No phaseTaking people
Weight Reduction in CLBP
Where
Rotterdam
Age
18 years to 65 years
People
84 worldwide
Run by
Vrije Universiteit Brussel
See details and how to joinNCT04824248
No phaseTaking people
Shift Workers' Health Behavior Action Program Across Europe
Where
Rotterdam, Wageningen
Age
21 years and over
People
400 worldwide
Run by
Wageningen University
See details and how to joinNCT07631767
Phase 3Taking people
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Where
Amsterdam, Beverwijk, Breda, Dirksland, Ede Gld, Eindhoven, Gouda, Groningen, Haarlem, Heerlen, Helmond, Leiderdorp, Nieuwegein, Roosendaal, Rotterdam, 'S-Hertogenbosch, Utrecht, Veldhoven, Venlo
Age
18 years and over
People
5,610 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00
No phaseTaking people
Effect of Probiotics on Appetite Regulation in Adults With Overweight/Obesity
Where
Maastricht
Age
20 years to 70 years
People
98
Run by
Maastricht University Medical Center
See details and how to joinNCT07715955
No phaseTaking people
Long-Term Effects of Walnut Consumption on Brain Function
Where
Maastricht
Age
45 years to 75 years
People
55
Run by
Maastricht University Medical Center
See details and how to joinNCT07422220
No phaseTaking people
DIStal gastriC Bypass OUtcome in Revision SurgEry After Roux-en-y Gastric Bypass
Where
Amsterdam, Arnhem, Eindhoven, Gouda, Leeuwarden, Nieuwegein, Roosendaal, Tilburg
Age
18 years to 65 years
People
150
Run by
St. Antonius Hospital
See details and how to joinNCT04894838
Phase 4Taking people
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)
Where
Rotterdam
Age
18 years to 75 years
People
70
Run by
Carmen Dietvorst
See details and how to joinNCT06845345 · EU 2024-519774-40-00
No phaseTaking people
Plant-based Protein-rich Weight Loss Intervention in 55+ Adults With Obesity
Where
Amsterdam
Age
55 years and over
People
200
Run by
Amsterdam University of Applied Sciences
See details and how to joinNCT07429136
No phaseTaking people
The Effects of a 4-week Supplementation With a Ketogenic Nutrient Mix on 24-hour Substrate Metabolism and Muscle Health
Where
Maastricht
Age
60 years to 80 years
People
14
Run by
Maastricht University Medical Center
See details and how to joinNCT07395973